Dr Andy Chevigné and Dr Martyna Szpakowska from the LIH Department of Infection and Immunity (DII) were rewarded for their outstanding contribution to molecular pharmacology during a virtual ceremony on Tuesday, December 8th, in the presence of Frank Vandenbroucke, Belgian Minister of Public Health and Social Affairs, and of representatives of pharmaceutical companies and healthcare hubs. The Galien Prize is traditionally organised in Belgium and Luxembourg by Roularta HealthCare on a yearly basis and crowns the most significant discoveries in the fields of pharmacology, drug development and medical devices.

WEBINAR: Lecture series Cancer Research: "Die or live trying - Cellular agony in anticancer immunity" - Prof Lorenzo Galluzzi

i2TRON is a highly innovative PhD training program on “integrating immune strategies for Translational Research in Oncology and Neurology” and is supported by the Luxembourg National Research Fund (FNR) within their PRIDE program. We will develop the next generation of translational scientists as boundary crossers, domain experts and skilled communicators. Inflammation is a common hallmark shared across different non-communicable diseases (NCD).

The Biostatistician will join the LIH’s CompetenceCenter for Methodology and Statistics (CCMS). Within the clinical research hub of theDepartment of Population Health, the CCMS provides methodological support instatistical planning, analysis & data handling for various laboratories andresearch groups. It also offers training in statistics as well as support inwriting papers.

WEBINAR: Lecture series Cancer Research: "Epigenetic signaling circuits in the tumor microenvironment that modulate invasion and metastasis" - Prof Douglas Hanahan

On Thursday, November 26th 2020, the Luxembourg Institute of Health (LIH) had the pleasure of welcoming the Director of the André Losch Foundation to its premises in Strassen for a visit of its Clinical and Epidemiological Investigation Centre (CIEC). The event also provided an opportunity to discuss the status of the COVID-19 projects coordinated by LIH and supported by the Foundation.

The Research Strategy Specialist will report to, and work in close partnership with the Director of the Department of Infection and Immunity, supporting and complementing the work of the LIH to deliver excellence in fundamental and biomedical research programmes in Luxembourg. Research at the Department of Infection and Immunity aims to understand the complex immune mechanisms of infections and inflammatory disease processes and cancer, enabling new ways to diagnose and prevent or cure human diseases caused by these disorders.

The European Commission confirmed its support to three new research projects involving the Luxembourg Institute of Health (LIH) submitted within the framework of the Horizon 2020 call “Innovative and rapid health-related approaches to respond to COVID-19 and to deliver quick results for society for a higher level of preparedness of health systems” (SC1-PHE-CORONAVIRUS-2020-2). The projects aim to foster the development of a novel diagnostic test and improve the cooperation between European and international cohorts to strengthen the response to the pandemic. The total funding for the studies amounts to EUR 26.2 million.

The University of Luxembourg, the Luxembourg Institute of Health (LIH) and the Luxembourg Institute of Science and Technology (LIST) announce the signing of mutual bilateral cooperation agreements between the University and LIH and between the University and LIST.